According to filings with the U.S. Securities and Exchange Commission, Raydiant Oximetry is raising up to $5,405,456.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Neil Ray played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Raydiant Oximetry
Raydiant Oximetry, Inc.. A company dedicated to the mission of keeping mothers and babies safe during childbirth. It is hard to imagine a greater honor and privilege than working towards this goal. We are developing a low-cost, non-invasive biomedical device to monitor the oxygen levels in fetal blood. This will help obstetricians and patients have more and better information that they need to ensure that it is safe to continue labor or confidently decide that a cesarean section is needed. It is our hope that we will improve maternal and fetal outcomes, decrease cesarean delivery rates, and thus overall decrease healthcare costs worldwide by doing so.

To learn more about Raydiant Oximetry, visit http://www.raydiantoximetry.com/
Company Linkedin Page: https://www.linkedin.com/company/raydiant-oximetry-inc./

Contact:
Neil Ray, Chief Executive Officer
650-822-7762
https://www.linkedin.com/in/neilpray/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.